Lietuvos vaikų nefrologų draugija - financials and debts

Company age: 26 y. 1 mo.

Update

Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue - - 235 790 11,219 11,044 1,320 2,596
Profit before tax - - - - 360 9,575 -1,587 0
Net profit - - - - 360 9,096 -1,587 0
Equity 162 162 162 744 360 9,096 7,509 5,344
Liabilities 65 65 65 65 65 544 49 223
Non-current assets 1 1 1 1 1 1 1 1
Current assets 47,418 47,542 46,652 48,958 49,069 60,806 59,034 65,232
Total assets 47,419 47,543 46,653 48,959 49,070 60,807 59,035 65,233
Financial indicators
Revenue change y/y - - - +236.2% +1320.1% -1.6% -88.0% +96.7%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. - - - - 0.7% 15.0% -2.7% 0.0%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. - - - - 100.0% 100.0% -21.1% 0.0%
Profit margin Net profit margin. Shows the overall profitability of the company. - - - - 3.2% 82.4% -120.2% 0.0%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. - - - - 3.2% 86.7% -120.2% 0.0%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 0.4 0.4 0.4 0.1 0.2 0.1 0.0 0.0
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. - - - - - - - -

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Social security debts

The company had no debts to Sodra

VMI tax arrears

The company had no tax arrears (debts) to the State Tax Inspectorate

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Lietuvos vaiku nefrologu draugija (code 195705545) is an association engaged in activities of professional membership organisations. In 2025, it generated EUR 2.6K in revenue, compared with EUR 1.3K in 2024 and EUR 11.0K in 2023, showing a rebound in annual turnover after a sharp decline from the 2023 level. The reported year-on-year revenue growth for 2025 was 96.7%, while the two-year change remained negative at -76.5%. Profitability was weaker in 2024, when the organisation recorded a net loss of EUR 1.6K after a net profit of EUR 9.1K in 2023; no net profit figure is provided for 2025. At the end of 2025, total assets stood at EUR 65.2K, equity at EUR 5.3K and liabilities at EUR 223. The equity ratio was 8.2%, debt-to-equity was 0.04, and asset turnover was 0.04x, indicating that assets were relatively large compared with revenue. The balance sheet remained lightly leveraged, with very limited liabilities and almost all assets in short-term form.